Paxil withdrawal. Paxil withdrawal side effects, Paxil withdrawal warnings, Paxil withdrawal precautions, Paxil withdrawal adverse effects, overdose, withdrawal symptoms and Paxil natural alternatives. Before you begin the spiral down with Paxil, try giving your body what it really wants.

Paxil Withdrawal

Paxil withdrawal. How to avoid Paxil withdrawal side effects click here

If you feel you or your child has been harmed by Paxil or your physician failed to inform you of risk associated with Paxil, you may want to seek the advice of an experienced Law Firm. Click here

Read Paxil side effects defined. Note: These Paxil side effects are also Paxil withdrawal side effects.

"I thank God for you guys everyday! I've tapered off Paxil using your program and feel better than I have in years. Your support is terrific and just knowing another person knows what I'm talking about is heartwarming. Thank you for your efforts!

Lisa B." Read more

There is a solution to Paxil withdrawal. The key is to use the right taper program. If you have already tried to quit Paxil and are in the middle of withdrawal with the "brain zaps" click here and get the right Omega 3 quickly.

Paxil - Alert from the F.D.A.

FDA ALERT [07/2005]: Suicidal Thoughts or Actions in Children and Adults

Patients with depression or other mental illnesses often think about or attempt suicide. Closely watch anyone taking antidepressants, especially early in treatment or when the dose is changed. Patients who become irritable or anxious, or have new or increased thoughts of suicide or other changes in mood or behavior (or their care givers) should contact their healthcare professional right away.

Children

Taking antidepressants may increase suicidal thoughts and actions in about 1 out of 50 people 18 years or younger. FDA has approved Zoloft for use in children only if they have obsessive-compulsive disorder.

Adults

Several recent scientific publications report the possibility of an increased risk for suicidal behavior in adults who are being treated with antidepressant medications. Even before these reports became available, FDA began a complete review of all available data to determine whether there is an increased risk of suicidal thinking or behavior in adults being treated with antidepressant medications. It is expected that this review will take a year or longer to complete. In the meantime, FDA is highlighting that adults being treated with antidepressant medication, particularly those being treated for depression, should be watched closely for worsening of depression and for increased suicidal thinking or behavior.

This information reflects FDA’s preliminary analysis of data concerning this drug. FDA is considering, but has not reached a final conclusion about, this information. FDA intends to update this sheet when additional information or analyses become available.

***Are you having "Brain Zaps" while using Paxil or during withdrawal? There is a solution.

April 25, 2006

Drip Drip Drip - Paxil Info Leaks Out

by Evelyn Pringle

http://www.opednews.com

Secrecy agreements in litigation hide information about defective products or a company’s negligence, and sometimes go so far as to prohibit the parties from discussing that there ever was a lawsuit. Such is the case with Paxil and as a result, unwitting patients continued to take the drug long after its dangers were known to GlaxoSmithKline.

Many lawsuits filed against Glaxo have been settled out of court, with confidential agreements that prevent the public from knowing about the harmful effects of the Paxil.

Previously sealed documents and internal company memos suppressed with protective orders, prove that Glaxo knew about the problems with Paxil before it received FDA approval, but continued to sell the drug for over a decade without warning consumers.

Long overdue legislation is currently pending in both the US House of Representatives and the Senate known as Sunshine in Litigation Act of 2005, which basically says that a court shall not enter an order restricting the disclosure of information obtained through discovery, an order approving a settlement agreement that would restrict the disclosure of such information, or an order restricting access to court records in a civil case

Glaxo currently faces thousands of lawsuits over Paxil side effects related to addiction, dependence, and a severe withdrawal syndrome.

SSRIs (selective serotonin reuptake inhibitors) like Paxil, are not addictive in the sense that “an individual would mortgage their livelihoods and all they hold dear for further supplies of the drug,” according to Dr David Healy MD, FRCPsych, North Wales Department of Psychological Medicine

SSRIs can hook patients in the sense of making you “physically dependent,” he explains.

Dr Healy, is considered an expert on Paxil and has had access to confidential studies from the Glaxo archives. The common symptoms of withdrawal, he says, break down into two groups. The first group may be unlike anything you have had before, he warns, to include:

Dizziness
Headache
Muscle Spasms
Tremor
Electric Shock-like Sensations
Other Strange Tingling or Painful Sensations
Nausea, Diarrhoea, Flatulence
Dreams, including Vivid Dreams
Agitation

The second group overlaps with general nervousness, Dr Healy says, and may lead to you or your physician to think that all you have are features of your original problem. These symptoms include:

Depression
Lability of Mood
Irritability
Agitation
Confusion
Fatigue/Malaise
Flu-like Feelings
Insomnia or Drowsiness
Mood Swings
Sweating
Feelings of Unreality
Feelings of being Hot or Cold

These symptoms appear in anywhere between 20% to 50% of patients taking SSRIs, Dr Healy says, sometimes within hours of the last dose.

In the class action case against Glaxo settled in 2005, In re: Paxil Products Liability Litigation, MDL No 1574, CD Calif, the plaintiffs were forever silenced by a strict confidentiality clause incorporated into the settlement agreement.

This author obtained a copy of the lawsuit’s complaint, dated August 23, 2001, as well as a copy of the settlement agreement with a secrecy clause that states in relevant part:

Plaintiffs and their attorneys, “will not make any statements, either directly or indirectly, by implication or innuendo, to anyone, including but not limited to consultants, experts, the press or media, concerning the amount or other terms of such settlement or settlements, or the nature and substance of settlement negotiations, or describing or characterizing the settlement in any way.”

Plaintiffs and their attorneys “will not, either directly or indirectly, publicize the fact of the settlement and that any inquiry into the settlement, its amount, meaning, interpretation or comparative value, or the negotiations leading to the settlement by anyone, including but not limited to the press or media, will be met only by a statement that the case has been resolved, and will decline any requests for interviews by the press or media regarding the settlement, its history or its terms.”

The clause even extends the internet specifically in that plaintiffs and attorneys “will not maintain and instead will discontinue any website references to Paxil discontinuation or withdrawal.”

And, it says, they “agree to refrain from any future internet postings regarding Paxil discontinuation or withdrawal.”

Paragraph 5 of the lawsuit’s complaint says that over a 2 years period, “plaintiffs' attorneys have been individually contacted by approximately 500 Paxil withdrawal victims.”

And, the pain and suffering experienced by each individual is the direct result of Glaxo’s “failure to warn users of Paxil’s addictive nature, the drug's inducement of physical or psychologic dependency, and its infliction of dependency/withdrawal syndrome when the patient's Paxil dosage is reduced or terminated,” the complaint states.

Paragraph 16, lists withdrawal reactions that “can summed up as one or more of the following complaints: jolting electric "zaps," dizziness, light headedness, vertigo, incoordination, gait disturbances, sweating, extreme nausea, vomiting, high fever, abdominal discomfort, flu symptoms, anorexia, diarrhea, agitation, tremulousness, irritability, aggression, sleep disturbance, nightmares, tremor, confusion, memory and concentration difficulties, lethargy, malaise, weakness, fatigue, paraesthesias, ataxia, and/or myalgia.”

Paragraph 7, says: “These reactions are "unexpected" to the victims and even their physicians because the manufacturer has deliberately failed to properly warn of this.”

“Both physician and patient unwittingly use Paxil without knowing the drug's addictive traits,” the complaint says.

Paragraph 8, charges that because Glaxo has suppressed the information, patients and physicians are fooled into thinking that the reactions are caused by another condition, such as relapse into depression, thus prompting incorrect and unnecessary medical treatment, including increased dosages of Paxil.

While researchers have acknowledged the potential for withdrawal reactions with all SSRIs, Paxil is by far the worst. Citing data from the World Health Organization, the lawsuit’s complaint states: “Paxil has the highest incidence rate of withdrawal adverse experiences of any antidepressant drug in the world.”

Starting in December 2001, Glaxo finally added a minimizing precaution to Paxil’s label of some possible "discontinuation" side effects affecting "2 percent or greater" of patients based on studies.

However, documents reveal that Glaxo has always known about the withdrawal syndrome. For instance, in 1993, in a report that occurred 5 months after Paxil arrived on the market, Stoker and Eric noted Paxil withdrawal at the American Psychiatric Association's annual meeting in San Francisco, May 22-27, 1993.

The authors of the study conducted 2 week tapering off periods for 186 patients in 6 to 12 week doubled blinded comparative studies. Low dose and high dose groups were studied. Paxil's low dose group actually did worse than the high dose group, suffering 42% withdrawal rate, compared to 38% in the high dose group. And, both occurred even though the tapering off regime was initiated during dosage reduction.

The lawsuit’s complaint specifically describes close to 10 studies that reveal a high rate of withdrawal symptoms since Paxil came on the market that Glaxo was fully aware of.

A fact well-evidenced in internal company documents. A previously suppressed, May 1, 1997, Glaxo memo to, “Paxil Selling Team,” on the “discontinuation syndrome,” defines the withdrawal syndrome as, "a class effect that can occur when an SSRI is stopped abruptly. Symptoms may include asthenia, flu-like symptoms, fatigue, dizziness, nausea, and sleep disturbances (insomnia, vivid dreams or nightmares)."

However, the memo instructs Glaxo sales representatives to avoid using the term and says: "instead of 'withdrawal syndrome,' which implies addictive properties, try to refer to this phenomenon as 'discontinuation symptoms.'"

Eight months later, in a December 1, 1997, "Business Plan Guide," sales representatives were instructed to "minimize concerns surrounding discontinuation symptoms," and told to explain to doctors that the "discontinuation incident rate is two in 1,000 patients."

However, according to a 1997 review, one study found that 25% of patients experienced at least one discontinuation symptoms, verses 5.9% taking a placebo. In another study of patients with major depression, 42% experienced at least 1 discontinuation symptom.

Another internal memo kept hidden with a protective order, states: “Discontinuation: why this is an issue,” followed by, “’97 Seroxat/Paxil sales to end Sept already exceed $1 Billion“.

This particular memo carries a cartoon-like picture of a big black money-bag.

In Paxil literature, Glaxo flat-out lied to patients and specifically said that the drug was not addictive. For example, a pamphlet made available at doctors’ offices and disseminated to patients, asked the question: “Is Paxil addictive?”

The pamphlet then states: “Paxil has been studied both in short-and long-term use and is not associated with dependence or addiction.”

The withdrawal syndrome is real and in fact, it is now known that infants of women who take SSRIs in the last 3 months of pregnancy, may experience symptoms of withdrawal, including convulsions, according to a study published in the February 4, 2005 issue of the journal Lancet.

In addition, experts warn against the use of Paxil and other SSRIs with children. According to Fred Baughman Jr, MD, an adult and child neurologist in private practice for 35 years, "most antidepressants have not proved effective in treating depression in children and some studies suggest they may cause some children to become acutely suicidal.”

Yet in 2002, Dr Baughman says, “nearly 11 million prescriptions for the drugs were given to children, 2.7 million of them to children under 12."

A report by an expert witness, previously sealed with a protective order, reveals how Glaxo concealed and manipulated data concerning Paxil-induced suicidality and how suicide attempts in studies by patients on Paxil were underreported and attempts by people taking a placebo were inflated.

Excerpts from the report were published by psychiatrist, Peter Breggin, MD, in Ethical Human Psychology and Psychiatry, (Volume 8, Spring 2006, pp. 77-84). Dr Breggin is a founder of the International Center for the Study of Psychiatry and Psychology (ICSPP) and the author of the Antidepressant Fact Book (2001).

His report also documents how Glaxo hid the incidence of akathisia (agitation with hyperactivity) and stimulation, which he says, are known risk factors for suicidality and violence.

Dr Breggin’s original report was based on a 3-day review of Glaxo’s sealed files, and was written for the California case of Lacuzong v GSK, and attached to a July 21, 2001, affidavit submitted in a case filed by the widow of a man who drowned their two children and himself in a tub after taking Paxil for three days.

At Glaxo’s insistence, the report remained sealed. However, in the more recent case of Moffett v Glaxo, in the US District Court for the South District of Mississippi, the report was filed in the public record.

“The drug companies,” says Dr Breggin, “settle almost all legal cases brought against them in order to seal incriminating scientific data.”

“The publication of a previously sealed medical expert report is a rare event,” he explains, “the first in my experience.”

In the book, The Antidepressant Solution, author Dr Joseph Glenmullen, a clinical instructor in psychiatry at Harvard Medical School, recommends tapering off antidepressants by following a 5-Step Antidepressant Tapering Program, to reduce both the incidence and severity of withdrawal reactions.

“Research has shown that when patients stop antidepressants cold turkey they can have high rates of withdrawal reactions,” Dr Glenmullen advises, “which vary depending on the particular drug.”

“In studies involving hundreds of patients, 66 percent of patients stopping Paxil,” he says, “have withdrawal reactions.”

For more information for injured parties go to Lawyers and Settlements.com

http://www.lawyersandsettlements.com/articles/paxil.html

Evelyn Pringle
evelyn.pringle@sbcglobal.net

Evelyn Pringle is a columnist for Independent Media TV and a freelance investigative journalist focused on exposing corruption in government

Contact Author

Paxil Suicide Product Liability Class Action Filed By Wrongful Death and Personal Injury Law Firm

Philadelphia, PA 19106		March 23 2006

National Class Action Filed against Drug-maker for Paxil-induced Suicides in Youths The mother of an 11-year old Wichita, Kansas boy who committed suicide on Paxil and a teenager from Pflugerville, Texas (a small town outside of Austin) who attempted suicide while taking Paxil, jointly filed a national class action lawsuit today in federal court in Philadelphia, Pennsylvania, the hometown of Paxil-maker, Glaxo SmithKline. The two plaintiffs theoretically represent all individuals under the age of 18 in the United States who attempted suicide or the families of individuals who killed themselves as a result of an adverse reaction to Paxil. The complaint charges include fraud, negligence, strict liability and breach of warranty. (See attached Lawsuit Allegations.) The FDA has required all antidepressant manufacturers to place a black box warning in their labels alerting physicians and patients to the increased risk of suicidality, which went into effect in January 2005. The Plaintiffs 11-year-old Trevor Blain was prescribed Paxil for “separation anxiety disorder” by his pediatrician in October 2000. He immediately began having difficulty sleeping and had angry outbursts while on Paxil, but his family did not make the connection between his deteriorating behavior and the drug. He continued taking the medication as prescribed. In early November 2000, Trevor hanged himself with his dog’s leash in the family laundry room. Although he survived the suicide attempt, he remained comatose for several weeks and died on December 7, 2000. 17-year-old Tonya Brooks was a shy high school student. Her family doctor diagnosed her with “social anxiety disorder” and prescribed Paxil in 2004. She became agitated, aggressive and had difficulty sleeping while taking Paxil. She first attempted suicide by taking an overdose of Paxil and a sleeping medication, Ambien. She survived the attempt and two days later gouged a hole in her leg with a pair of scissors. She was hospitalized for several days. Tonya is one of six youths featured in a new documentary film entitled “Prescription: Suicide?” The film will be screened at the upcoming Beverly Hills Film Festival on April 8, 2006. The documentary takes an intimate look at children and teens who have committed suicide or attempted suicide while taking antidepressants and the impact these tragic events have had on their families. Tonya's mother, Cheryl Brooks stated: “No parent should have to go through what we did.” Explaining her horror when she found her daughter sprawled on the bathroom floor after her suicide attempt, Mrs. Brooks stated: "[T]here was blood everywhere.... [The manufacturers of these drugs] should be paying for this. They gave these medicines to these kids - that's murder...” Baum Hedlund partner, Karen Barth Menzies, stated regarding the lawsuit: “Through our Paxil litigation, we've obtained documents that show a seriously troubling mentality of profit over safety and a callous disregard for the welfare of children. That’s about as reprehensible as you can get. Governmental regulators around the world have now analyzed the actual data from the clinical trials, not GSK’s version of it, and have found an increased risk of suicidality. Yet the drug companies and their hired mouthpieces in the medical academic community, including the pediatric arm of the APA [American Psychiatric Association], continue to downplay the Black Box Warning as an “over-reaction” by FDA. They continue to try to hide this risk from parents for the sake of profits. We wanted to make sure the rights of all of these kids are protected by filing this lawsuit.” The Lawsuit’s Allegations • Paxil was introduced into the U.S. market on December 29, 1992, and is a well known antidepressant medication in the same class as Prozac, Zoloft, Effexor, Celexa and Lexapro (selective serotonin reuptake inhibitors or "SSRI’s”). Paxil is approved for marketing in the United States for conditions such as depression, obsessive compulsive disorder, panic disorder, and “social anxiety disorder.” It is not approved for pediatric use. • Although a number of clinical trials have been conducted in the pediatric population, Paxil has never been approved by the FDA for use in children/adolescents because the studies show that the drug doesn’t work. (¶ 18.) • The studies show a more than doubling of the risk and in one study, there was a nearly 6 times increase of suicidal thoughts and behavior compared to placebo. (¶ 19.) • Not until 2002 was it recognized that GSK had been coding suicidal behavior as “emotional lability,” thus hiding the risk. (¶ 19.) • Notwithstanding the clinical trials which showed Paxil to be ineffective for pediatric patients and associated with an increased risk of serious, and possibly deadly, side effects, GSK engaged in a campaign to promote the use of Paxil for use with pediatric patients. (¶ 20.) • GSK, faced with the negative results from the pediatric studies, began a campaign to reduce the negative impact of this bad study data. GSK prepared a medical journal article regarding Study 329 that was not only “ghost written,” but falsely stated that Paxil was superior to placebo among “four of the parameters,” including one which was identified as a “primary outcome measure.” In fact, GSK knew that Paxil was not found to be superior to placebo amongst any of the “primary outcome measures.” Further, the article stated that “most adverse effects were not serious,” and failed to list suicide-related events as “serious.” (¶ 20.) • In a document directed to “all sales representatives selling Paxil,” a GSK manager stated that, according to the “Keller” article, “Paxil demonstrates REMARKABLE Efficacy and Safety in the treatment of adolescent depression.” (emphasis in original). The document states that “the findings of this study provide evidence of the efficacy and safety of Paxil in the treatment of adolescent depression.” As GSK well knew, study 329 found Paxil to be neither effective nor safe. (¶ 20.) • GSK also hired doctors to go around the world and promote the use of Paxil for pediatric patients by way of “posters” and lectures at medical conferences. These “posters” and their presenters claimed that Paxil was effective for treating adolescent depression and free from serious side effects. In fact, GSK knew that to be false. (¶ 21.) • In internal, unpublished documents, which have been kept from public and regulatory scrutiny via the stratagem of over-broad “confidentiality” designations, GSK has made numerous admissions about Paxil’s associated harmful side effects and lack of effectiveness in children and adolescents. Notwithstanding these admissions, in flagrant and conscious disregard and indifference, GSK has denied publicly that such nexus exists, and has failed utterly to take any measures whatsoever to alert the public, the prescribing physicians, and the patients who take it, of the incipient dangers associated with Paxil. (¶ 72.) • GSK has defrauded the medical profession, the Paxil patient population, and the general public in that it, among other acts: (a) Hired a firm to “ghostwrite” an article that was widely publicized which claimed, falsely, that Paxil was effective and safe for the treatment of depression with children and adolescents; (b) Hired doctors to present “posters” around the world at medical conferences which claimed, falsely, that Paxil was effective and safe for the treatment of depression with children and adolescents; (c) Fraudulently mischaracterized and miscoded adverse events involving self-harm with the term “emotional lability” so as to reduce the number of occurrences and hide their existence from the public and regulators; (d) Failed to inform the medical and research communities that a significant number of pediatric patients taking Paxil during clinical trials attempted acts of self-harm at a rate that was at least twice that for pediatric patients who took placebo; (e) Fraudulently claimed that Paxil’s characteristic side effects of insomnia, agitation and anxiety were of little or no concern when in fact these effects are known to be among the most critical and deadly of the short-term risk factors for self-harm; (f) Fraudulently denied Paxil’s association with serious or deadly thoughts or acts of self-harm when its own investigators informed GSK (and GSK determined itself) that Paxil was associated with such conditions; (g) Allowing the use of concomitant medications in clinical trials to lessen side effects in order to avoid the reporting of treatment-emergent adverse events, such as akathisia; (h) Aggressively promoted Paxil to doctors for use with pediatric patients even though Paxil was not, and is not, approved for use with children and adolescents. (¶ 73.) • In early 2005, GSK updated Paxil’s label to include a “black-box” warning, which is the strongest warning allowed for by FDA regulations. That warning states: Suicidality in Children and Adolescents Antidepressants increased the risk of suicidal thinking and behavior (suicidality) in short-term studies in children and adolescents with Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of PAXIL or any other antidepressant in a child or adolescent must balance this risk with the clinical need. Patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. PAXIL is not approved for use in pediatric patients. (See WARNINGS and PRECAUTIONS -- Pediatric Use) Pooled analysis of short-term (4 to 16 weeks) placebo-controlled trials of 9 antidepressant drugs (SSRIs and others) in children and adolescents with major depressive disorder (MDD), obsessive compulsive disorder (OCD), or other psychiatric disorders (a total of 24 trials involving over 4,400 patients) have revealed a greater risk of adverse events representing suicidal thinking or behavior (suicidality) during the first few months of treatment in those receiving antidepressants. The average risk of such events in patients receiving antidepressants was 4%, twice the placebo risk of 2%. No suicides occurred in these trials. (¶ 28.)

Paxil withdrawal Body

Paxil withdrawal Dry Mouth - The usual amount to moisture in the mouth is noticeably less.

Paxil withdrawal Sweating Increased - A large quantity of perspiration that is medically caused.

Paxil withdrawal Cardiovascular (Involving the heart and the blood vessels)

Paxil withdrawal Palpitation - Unusual and not normal heartbeat, that is sometimes irregular, but rapid and forceful thumping or fluttering. It can be brought on by shock, excitement, exertion, or medical stimulants. A person is normally unaware of his/her heartbeat.

Paxil withdrawal Hypertension - is high blood pressure, which is a symptom of disease in the blood vessels leading away from the heart. Hypertension is known as the “silent killer”. The symptoms are usually not obvious, however it can lead to damage to the heart, brain, kidneys and eye, and even to stroke and kidney failure. Treatment includes dietary and lifestyle changes.

Paxil withdrawal Bradycardia - The heart rate is slowed from 72 beats per minute, which is normal, to below 60 beats per minute in an adult.

Paxil withdrawal Tachycardia - The heart rate is speeded up to above 100 beats per minute in an adult. Normal adult heart rate is 72 beats per minute.

Paxil withdrawal ECG Abnormal - A test called an electrocardiogram (ECG) that records the activity of the heart. It measures heartbeats as will as the position and size of the heart’s four chambers. It also measures if there is damage to the heart and the effects of drugs or mechanical devices like a pacemaker on the heart. When the test is abnormal this means that one or more of the following are present: heart disease, defects, beating too fast or too slow, disease of the blood vessels leading from the heart or of the heart valves, and/or a past or about to occur heart attack.

Paxil withdrawal Flushing - The skin all over the body turns red.

Paxil withdrawal Varicose Vein - Unusually swollen veins near the surface of the skin that sometimes appear twisted and knotted, but always enlarged. They are called hemorrhoids when they appear around the rectum. The cause is attributed to hereditary weakness in the veins aggravated by obesity, pregnancy, pressure from standing, aging, etc. Severe cases may develop swelling in the legs, ankles and feet, eczema and/or ulcers in the affected areas.

Paxil withdrawal Gastrointestinal (Involving the stomach and the intestines)

Paxil withdrawal Abdominal Cramp/Pain - Sudden, severe, uncontrollable and painful shortening and thickening of the muscles in the belly. The belly includes the stomach as well as the intestines, liver, kidneys, pancreas, spleen, gall bladder, and urinary bladder.

Paxil withdrawal Belching - Noisy release of gas from the stomach through the mouth; a burp.

Paxil withdrawal Bloating - Swelling of the belly caused by excessive intestinal gas.

Paxil withdrawal Constipation - Difficulty in having a bowel movement where the material in the bowels is hard due to a lack of exercise, fluid intake, and roughage in the diet, or due to certain drugs.

Paxil withdrawal Diarrhea - Unusually frequent and excessive, runny bowel movements that may result in severe dehydration and shock.

Paxil withdrawal Dyspepsia - Indigestion. This is the discomfort you experience after eating. It can be heartburn, gas, nausea, a bellyache or bloating.

Paxil withdrawal Flatulence - More gas than normal in the digestive organs.

Paxil withdrawal Gagging - Involuntary choking and/or involuntary throwing up.

Paxil withdrawal Gastritis - A severe irritation of the mucus lining of the stomach either short in duration or lasting for a long period of time.

Paxil withdrawal Gastroenteritis - A condition where the membranes of the stomach and intestines are irritated.

Paxil withdrawal Gastroesophageal Reflux - A continuous state where stomach juices flow back into the throat causing acid indigestion and heartburn and possibly injury to the throat.

Paxil withdrawal Heartburn - A burning pain in the area of the breastbone caused by stomach juices flowing back up into the throat.

Paxil withdrawal Hemorrhoids - Small rounded purplish swollen veins that either bleed, itch or are painful and appear around the anus.

Paxil withdrawal Increased Stool frequency - Diarrhea.

Paxil withdrawal Indigestion - Unable to properly consume and absorb food in the digestive tract causing constipation, nausea, stomach ache, gas, swollen belly, pain and general discomfort or sickness.

Paxil withdrawal Nausea - Stomach irritation with a queasy sensation similar to motion sickness and a feeling that one is going to vomit.

Paxil withdrawal Polyposis Gastric - Tumors that grow on stems in the lining of the stomach, which usually become cancerous.

Paxil withdrawal Swallowing Difficulty - A feeling that food is stuck in the throat or upper chest area and won’t go down, making it difficult to swallow.

Paxil withdrawal Toothache - Pain in a tooth above and below the gum line.

Paxil withdrawal Vomiting - Involuntarily throwing up the contents of the stomach and usually getting a nauseated, sick feeling just prior to doing so.

Paxil withdrawal General

Paxil withdrawal Allergy - The extreme sensitivity of body tissues triggered by substances in the air, drugs, or foods causing a reaction like sneezing, itching, asthma, hay fever, skin rashes, nausea and/or vomiting.

Paxil withdrawal Anaphylaxis - A violent, sudden, and severe drop in blood pressure caused by a re-exposure to a foreign protein or a second dosage of a drug that may be fatal unless emergency treatment is given right away.

Paxil withdrawal Asthenia - A physically weak condition.

Paxil withdrawal Chest Pains - Severe discomfort in the chest caused by not enough oxygen going to the heart because of narrowing of the blood vessels or spasms.

Paxil withdrawal Chills - Appearing pale while cold and shivering; sometimes with a fever.

Paxil withdrawal Edema of Extremities - Abnormal swelling of the body’s tissue caused by the collection of fluid.

Paxil withdrawal Fall - To suddenly lose your normal standing upright position as if you were shot.

Paxil withdrawal Fatigue - Loss of normal strength so as to not be able to do the usual physical and mental activities.

Paxil withdrawal Fever - Abnormally high body temperature, the normal being 98 degrees Fahrenheit or 37 degrees Centigrade in humans, which is a symptom of disease or disorder in the body. The body is affected by feeling hot, chilled, sweaty, weak and exhausted. If the fever goes too high, death can result.

Paxil withdrawal Hot Flashes - Brief, abnormal enlargement of the blood vessels that causes a sudden heat sensation over the entire body. Women in menopause will sometimes experience this.

Paxil withdrawal Influenza-like Symptoms - Demonstrating irritation of the respiratory tract (organs of breathing) such as a cold, sudden fever, aches and pains, as well as feeling weak and seeking bed rest, which is similar to having the flu.

Paxil withdrawal Leg Pain - A hurtful sensation in the legs that is caused by excessive stimulation of the nerve endings in the legs and results in extreme discomfort.

Paxil withdrawal Malaise - The somewhat unclear feeling of discomfort you get when you start to feel sick.

Paxil withdrawal Pain in Limb - Sudden, sharp and uncontrolled leg discomfort.

Paxil withdrawal Syncope - A short period of light headedness or unconsciousness (black-out) also know as fainting caused by lack of oxygen to the brain because of an interruption in blood flowing to the brain.

Paxil withdrawal Tightness of Chest - Mild or sharp discomfort, tightness or pressure in the chest area (anywhere between the throat and belly). The causes can be mild or seriously life-threatening because they include the heart, lungs and surrounding muscles.

Paxil withdrawal Hemic and Lymphatic Disorders (Involving the blood and the clear fluids in the tissues that contain white blood cells)

Paxil withdrawal Bruise - Damage to the skin resulting in a purple-green-yellow skin coloration that’s caused by breaking the blood vessels in the area without breaking the surface of the skin.

Paxil withdrawal Anemia - A condition where the blood is no longer carrying enough oxygen, so the person looks pale and easily gets dizzy, weak and tired. More severely, a person can end up with an abnormal heart, as well as breathing and digestive difficulties. The causes of anemia are not enough protein in the red blood cells, or missing and chemically destroyed red blood cells, as well as diseased or destroyed bone marrow.

Paxil withdrawal Nosebleed - Blood lost from the part of the face that has the organs of smell and is where the body takes in oxygen.

Paxil withdrawal Hematoma - Broken blood vessels that cause a swelling in an area on the body.

Paxil withdrawal Lymphadenopathy Cervical - The lymph nodes in the neck, which are part of the body’s immune system get swollen and enlarge by reacting to the presence of a drug. The swelling is the result of the white blood cells multiplying in order to fight the invasion of the drug.

Paxil withdrawal Metabolic and Nutritional Disorders (Energy and health)

Paxil withdrawal Arthralgia - Sudden sharp nerve pain in one or more joints.

Paxil withdrawal Arthropathy - Having joint disease or abnormal joints.

Paxil withdrawal Arthritis - Painfully inflamed and swollen joints. The reddened and swollen condition is brought on by a serious injury or shock to the body either from physical or emotional causes.

Paxil withdrawal Back Discomfort - Severe physical distress in the area from the neck to the pelvis along the backbone.

Paxil withdrawal Bilirubin Increased - Bilirubin is a waste product of the breakdown of old blood cells. Bilirubin is sent to the liver to be made water-soluble so it can be eliminated from the body through emptying the bladder. A drug can interfere with or damage this normal liver function creating liver disease.

Paxil withdrawal Decreased Weight - Uncontrolled and measured loss of heaviness or weight.

Paxil withdrawal Gout - A severe arthritis condition that is caused by the dumping of a waste product called uric acid in the tissues and joints. It can become worse and cause the body to develop a deformity after going through stages of pain, inflammation, severe tenderness, and stiffness.

Paxil withdrawal Hepatic Enzymes Increased - An increase in the amount of paired liver proteins that regulate liver processes causing a condition where the liver functions abnormally.

Paxil withdrawal Hypercholesterolemia - Too much cholesterol in the blood cells.

Paxil withdrawal Hyperglycemia - An unhealthy amount of sugar in the blood.

Paxil withdrawal Increased Weight - A concentration and storage of fat in the body accumulating over a period of time caused by unhealthy eating patterns, that can predispose the body to many disorders and diseases.

Paxil withdrawal Jaw Pain - The pain due to irritation and swelling of the nerves associated with the mouth area where it opens and closes just in front of the ear. Some of the symptoms are pain when chewing, head aches, losing your balance, stuffy ears or ringing in the ears, and teeth grinding.

Paxil withdrawal Jaw Stiffness - The result of squeezing and grinding the teeth while asleep that can cause your teeth to deteriorate as well as the muscles and joints of the jaw.

Paxil withdrawal Joint Stiffness - A loss of free motion and easy flexibility where any two bones come together.

Paxil withdrawal Muscle Cramp - When muscles contract uncontrollably without warning and do not relax. The muscles of any of the body’s organs can cramp.

Paxil withdrawal Muscle Stiffness - Tightening of muscles making it difficult to bend.

Paxil withdrawal Muscle Weakness - Loss of physical strength.

Paxil withdrawal Myalgia - A general widespread pain and tenderness of the muscles.

Paxil withdrawal Thirst - A strong, unnatural craving for moisture/water in the mouth and throat.

Paxil withdrawal Nervous System (Sensory channels)

Paxil withdrawal Carpal Tunnel Syndrome - A pinched nerve in the wrist that causes pain, tingling, and numbing.

Paxil withdrawal Coordination Abnormal - A lack of normal, harmonious interaction of the parts of the body when it is in motion.

Paxil withdrawal Dizziness - Losing one’s balance while feeling unsteady and lightheaded which may lead to fainting.

Paxil withdrawal Disequilibrium - Lack of mental and emotional balance.

Paxil withdrawal Faintness - A temporary condition where one is likely to go unconscious and fall.

Paxil withdrawal Headache - A sharp or dull persistent pain in the head

Paxil withdrawal Hyperreflexia - A not normal and involuntary increased response in the tissues connecting the bones to the muscles.

Paxil withdrawal Light-headed Feeling – Uncontrolled and usually brief loss of consciousness caused by lack of oxygen to the brain.

Paxil withdrawal Migraine - Reoccurring severe head pain usually with nausea, vomiting, dizziness, flashes or spots before the eyes, and ringing in the ears

Paxil withdrawal Muscle Contractions Involuntary - Spontaneous and uncontrollable tightening reaction of the muscles caused by electrical impulses from the nervous system.

Paxil withdrawal Muscular Tone Increased - Uncontrolled and exaggeration muscle tension. Muscles are normally partially tensed and this is what gives us muscle tone.

Paxil withdrawal Paresthesia - Burning, prickly, itchy, or tingling skin with no obvious or understood physical cause.

Paxil withdrawal Restless Legs - A need to move the legs without any apparent reason. Sometimes there is pain, twitching, jerking, cramping, burning, or a creepy-crawly sensation associated with the movements. It worsens when a person is inactive and can interrupt one’s sleep so one feels the need to move to gain some relief.

Paxil withdrawal Shaking - Uncontrolled quivering and trembling as if one is cold and chilled.

Paxil withdrawal Sluggishness - Lack of alertness and energy, as well as being slow to respond or perform in life.

Paxil withdrawal Tics - A contraction of a muscle causing a repeated movement not under the control of the person usually on the face or limbs.

Paxil withdrawal Tremor - A nervous and involuntary vibrating or quivering of the body.

Paxil withdrawal Twitching - Sharp, jerky and spastic motion sometimes with a sharp sudden pain.

Paxil withdrawal Vertigo - A sensation of dizziness with disorientation and confusion.

Paxil withdrawal Psychiatric Disorders (Mental and emotional)

Paxil withdrawal Aggravated Nervousness - A progressively worsening, irritated and troubled state of mind.

Paxil withdrawal Agitation - Suddenly violent and forceful, emotionally disturbed state of mind.

Paxil withdrawal Amnesia - Long term or short term, partial or full memory loss created by emotional or physical shock, severe illness, or a blow to the head where the person was caused pain and became unconsciousness.

Paxil withdrawal Anxiety Attack - Sudden and intense feelings of fear, terror, and dread physically creating shortness of breath, sweating, trembling and heart palpitations.

Paxil withdrawal Apathy - Complete lack of concern or interest for things that ordinarily would be regarded as important or would normally cause concern.

Paxil withdrawal Appetite Decreased - Having a lack of appetite despite the ordinary caloric demands of living with a resulting unintentional loss of weight.

Paxil withdrawal Appetite Increased - An unusual hunger causing one to overeat.

Paxil withdrawal Auditory Hallucination - Hearing things without the voices or noises being present.

Paxil withdrawal Bruxism - Grinding and clenching of teeth while sleeping.

Paxil withdrawal Carbohydrate Craving - A drive and craving to eat foods rich in sugar and starches (sweets, snacks and junk foods) that intensifies as the diet becomes more and more unbalanced due to the unbalancing of the proper nutritional requirements of the body.

Paxil withdrawal Concentration Impaired - Unable to easily focus your attention for long periods of time.

Paxil withdrawal Confusion - Not able to think clearly and understand in order to make a logical decision.

Paxil withdrawal Crying Abnormal - Unusual and not normal fits of weeping for short or long periods of time for no apparent reason.

Paxil withdrawal Depersonalization - A condition where one has lost a normal sense of personal identity.

Paxil withdrawal Depression - A hopeless feeling of failure, loss and sadness that can deteriorate into thoughts of death.

Paxil withdrawal Disorientation - A loss of sense of direction, place, time or surroundings as well as mental confusion on personal identity.

Paxil withdrawal Dreaming Abnormal - Dreaming that leaves a very clear, detailed picture and impression when awake that can last for a long period of time and sometimes be unpleasant.

Paxil withdrawal Emotional Lability - Suddenly breaking out in laughter or crying or doing both without being able to control the outburst of emotion. These episodes are unstable as they are caused by things that normally would not have this effect on an individual.

Paxil withdrawal Excitability - Uncontrollably responding to stimuli.

Paxil withdrawal Feeling Unreal - The awareness that one has an undesirable emotion like fear but can’t seem to shake off the irrational feeling. For example, feeling like one is going crazy but rationally knowing that it is not true. The quality of this side effect resembles being in a bad dream and not being able to wake up.

Paxil withdrawal Forgetfulness - Unable to remember what one ordinarily would remember.

Paxil withdrawal Insomnia - Sleeplessness caused by physical stress, mental stress or stimulants such as coffee or medications; it is a condition of being abnormally awake when one would ordinarily be able to fall and remain asleep.

Paxil withdrawal Irritability - Abnormally annoyed in response to a stimulus.

Paxil withdrawal Jitteriness - Nervous fidgeting without an apparent cause.

Paxil withdrawal Lethargy - Mental and physical sluggishness and apathy that can deteriorate into an unconscious state resembling deep sleep. A numbed state of mind.

Paxil withdrawal Libido Decreased - An abnormal loss of sexual energy or desire.

Paxil withdrawal Panic Reaction - A sudden, overpowering, chaotic and confused mental state of terror resulting in being doubt ridden often accompanied with hyperventilation, and extreme anxiety.

Paxil withdrawal Restlessness Aggravated - A constantly worsening troubled state of mind characterized by the person being increasingly nervous, unable to relax, and easily angered.

Paxil withdrawal Somnolence - Feeling sleepy all the time or having a condition of semi-consciousness.

Paxil withdrawal Suicide Attempt - An unsuccessful deliberate attack on one’s own life with the intention of ending it.

Paxil withdrawal Suicidal Tendency - Most likely will attempt to kill oneself.

Paxil withdrawal Tremulousness Nervous - Very jumpy, shaky, and uneasy while feeling fearful and timid. The condition is characterized by thoughts of dreading the future, involuntary quivering, trembling, and feeling distressed and suddenly upset.

Paxil withdrawal Yawning - involuntary opening of the mouth with deep inhalation of air.

Paxil withdrawal Reproductive Disorder Female

Paxil withdrawal Breast Neoplasm - A tumor or cancer, of either of the two milk-secreting organs on the chest of a woman.

Paxil withdrawal Menorrhagia - Abnormally heavy menstrual period or a menstrual flow that has continued for an unusually long period of time.

Paxil withdrawal Menstrual Cramps - Painful, involuntary uterus contractions that women experience around the time of their menstrual period, sometimes causing pain in the lower back and thighs.

Paxil withdrawal Menstrual Disorder - A disturbance or derangement in the normal function of a woman’s menstrual period.

Paxil withdrawal Pelvic Inflammation - The reaction of the body to infectious, allergic, or chemical irritation, which in turn causes tissue irritation, injury, or bacterial infection characterized by pain, redness, swelling, and sometimes loss of function. The reaction usually begins in the uterus and spreads to the fallopian tubes, ovaries, and other areas in the hipbone region of the body.

Paxil withdrawal Premenstrual Syndrome - Various physical and mental symptoms commonly experienced by women of childbearing age usually 2 to 7 days before the start of their monthly period. There are over 150 symptoms including eating binges, behavioral changes, moodiness, irritability, fatigue, fluid retention, breast tenderness, headaches, bloating, anxiety, and depression. The symptoms cease shortly after the period begins, and disappear with menopause.

Paxil withdrawal Spotting Between Menses - Abnormal bleeding between periods. Unusual spotting between menstrual cycles.

Paxil withdrawal RESPIRATORY SYSTEM (Organs involved in breathing)

Paxil withdrawal Asthma - A disease of the breathing system initiated by and allergic reaction or a chemical with repeated attacks of coughing, sticky mucus, wheezing, shortness of breath, and a tight feeling in the chest. The disease can reach a state where it stops a person from exhaling, leading to unconsciousness and death.

Paxil withdrawal Breath Shortness - Unnatural breathing using a lot off effort resulting in not enough air taken in by the body.

Paxil withdrawal Bronchitis - Inflammation of the two main breathing tubes leading from the windpipe to the lungs. The disease is marked with coughing, a low-grade fever, chest pains, and hoarseness, caused by an allergic reaction.

Paxil withdrawal Coughing - A cough is the response to an irritation, such as mucus, that causes the muscles controlling the breathing process to expel air from the lungs suddenly and noisily to keep the air passages free from the irritating material.

Paxil withdrawal Laryngitis - Inflammation of the voice box characterized by hoarseness, sore throat, and coughing. It can be cause by straining the voice or exposure to infectious, allergic or chemical irritation.

Paxil withdrawal Nasal Congestion - The presence of an abnormal amount of fluid in the nose.

Paxil withdrawal Pneumonia Tracheitis - Bacterial infection of the air passageways and lungs that causes redness, swelling and pain in the windpipe. Other symptoms are high fever, chills, pain in the chest, difficulty in breathing, and coughing with mucus discharge.

Paxil withdrawal Rhinitis - Chemical irritation causing pain, redness and swelling in the mucus membranes of the nose.

Paxil withdrawal Sinus Congestion - The mucus-lined areas of the bones in the face that are thought to help warm and moisten air to the nose. These areas become clogged with excess fluid or infected.

Paxil withdrawal Sinus Headache - The abnormal amount of fluid in the hollows of the face bone area especially around the nose. This excess fluid creates pressure, causing pain in the head.

Paxil withdrawal Sinusitis - The body reacting to chemical irritation causing redness, swelling and pain in the area of the hollows in the facial bones especially around the nose.

Paxil withdrawal SKELETAL

Paxil withdrawal Neck/Shoulder Pain - Hurtful sensations of the nerve endings caused by damage to the tissues in the neck and shoulder signaling danger of disease.

Paxil withdrawal SKIN and APPENDAGES DISORDERS (Skin, legs and arms)

Paxil withdrawal Acne - Eruptions of the oils glands of the skin, especially on the face, marked by pimples, blackheads, whiteheads, bumps, and more severely, by cysts and scarring.

Paxil withdrawal Alopecia - The loss of hair or baldness.

Paxil withdrawal Eczema - A severe or continuing skin disease marked by redness, crusting and scaling with watery blisters and itching. It is often difficult to treat and will sometimes go away only to reappear again.

Paxil withdrawal Dermatitis - Generally irritated skin that can be caused by any of a number of irritating things such as parasites, fungus, bacteria, or foreign substances causing an allergic reaction. It is a general inflammation of the skin.

Paxil withdrawal Dry Lips - The lack of normal moisture in the fleshy folds that surround the mouth.

Paxil withdrawal Dry Skin - The lack of normal moisture/oils in the surface layer of the body. The skin is the body’s largest organ.

Paxil withdrawal Folliculitis - Inflammation of a follicle (small body sac) especially a hair follicle. A hair follicle contains the root of a hair.

Paxil withdrawal Furunculosis - Skin boils that show up repeatedly.

Paxil withdrawal Lipoma - A tumor of mostly fat cells that is not health endangering.

Paxil withdrawal Pruritus - Extreme itching of often-undamaged skin.

Paxil withdrawal Rash - A skin eruption or discoloration that may or may not be itching, tingling, burning, or painful. It may be caused by an allergy, an skin irritation, a skin disease.

Paxil withdrawal Skin Nodule - A bulge, knob, swelling or outgrowth in the skin that is a mass of tissue or cells.

Paxil withdrawal SPECIAL SENSES

Paxil withdrawal Conjunctivitis - Infection of the membrane that covers the eyeball and lines the eyelid, caused by a virus, allergic reaction, or an irritating chemical. It is characterized by redness, a discharge of fluid and itching.

Paxil withdrawal Dry Eyes - Not enough moisture in the eyes.

Paxil withdrawal Earache - Pain in the ear.

Paxil withdrawal Eye Infection - The invasion of the eye tissue by a bacteria, virus, fungus, etc, causing damage to the tissue, with toxicity. Infection spreading in the body progresses into disease.

Paxil withdrawal Eye Irritation - An inflammation of the eye.

Paxil withdrawal Metallic Taste - A range of taste impairment from distorted taste to a complete loss of taste.

Paxil withdrawal Pupils Dilated - Abnormal expansion of the blace circular opening in the center of the eye.

Paxil withdrawal Taste alteration - Abnormal flavor detection in food.

Paxil withdrawal Tinnitus

Paxil withdrawal. Paxil withdrawal side effects, Paxil withdrawal warnings, Paxil withdrawal precautions, Paxil withdrawal adverse effects, overdose, withdrawal symptoms and Paxil natural alternatives. Before you begin the spiral down with Paxil, try giving your body what it really wants.